Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus aspirin plus clopidogrel for prevention of saphenous vein graft occlusion after CABG
KCT0003991Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis and saphenous vein graft degeneration (SVGD) comparing Aspirin monotherapy with Aspirin plus clopidogrel (2 arms). Started Sep 2019; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary arteriosclerosissaphenous vein graft degeneration (SVGD)
Beyond the preview
Go deeper on KCT0003991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003991.